In a surprising turn of events, the F.D.A. has authorized a clinical trial to study the effectiveness of marijuana in treating PTSD in veterans, symbolizing a shift in policy regarding the therapeutic use of cannabis.
As addiction and overdose rates rise, the agency acknowledges an urgent need for alternative mental health treatments, leading to a decision that breaks traditional barriers for marijuana research.
Historically, the F.D.A. has focused on the dangers of marijuana. However, changes in public perception and state-level legalization are influencing new research into its therapeutic applications.
The recent authorization reflects a growing acknowledgment from federal officials regarding the potential benefits of cannabis, moving from a regulatory perspective centered on harm to one that embraces research into its medical value.
Collection
[
|
...
]